Return to content in this issue


Excipients as potential agents of anaphylaxis in vaccines: analyzing the formulations of the current authorized COVID-19 vaccines

Caballero ML, Quirce S

Department of Allergy, La Paz University Hospital, IdiPAZ, Madrid, Spain.

J Investig Allergol Clin Immunol 2021; Vol. 31(1)
doi: 10.18176/jiaci.0667

Key words: Allergy, Anaphylaxis, Coronavirus, COVID-19, Drug immediate hypersensitivity reaction, Excipient, Pharmaceutical excipients, Vaccine